0001209191-20-036618.txt : 20200615
0001209191-20-036618.hdr.sgml : 20200615
20200615163255
ACCESSION NUMBER: 0001209191-20-036618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200615
DATE AS OF CHANGE: 20200615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mathers Edward T
CENTRAL INDEX KEY: 0001328625
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 20963790
MAIL ADDRESS:
STREET 1: C/O MEDIMMUNE, INC.
STREET 2: ONE MEDIMMUNE WAY
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 1050
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-11
0
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001328625
Mathers Edward T
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD
21093
1
0
0
0
Stock Option (right to buy)
16.71
2020-06-11
4
A
0
17000
0.00
A
2030-06-10
Common Stock
17000
17000
D
The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's
2021 annual stockholder meeting.
/s/ Sasha Keough, attorney-in-fact
2020-06-15